The Conflicts That Result From Globalizing Euro-American Psychology in India
Researchers examine the transformation of work, life, and identity in India as a result of Western corporate and psychological culture.
Transcranial Magnetic Stimulation No Better Than Placebo for Treatment-Resistant Depression
A new study in JAMA Psychiatry found that transcranial magnetic stimulation was no better than placebo for treatment-resistant depression.
Adverse Effects: The Perils of Deep Brain Stimulation for Depression
Hundreds of people have been given remote control deep brain stimulation implants for psychiatric disorders such as depression, OCD and Tourette’s. Yet DBS specialists still have no clue about its mechanisms of action and research suggests its hefty health and safety risks far outweigh benefits.
Study Finds Hearing Voices Groups Improve Social and Emotional Wellbeing
Hearing Voices Network self-help groups are an important resource for coping with voice hearing, study finds.
Antidepressants Do Not Prevent Suicides, May Increase Risk
When the CDC released data revealing an increasing suicide rate in the US, some experts, speaking to major media outlets, speculated that the increase...
Textbooks Provide Misleading Information on the Neurobiology of ADHD
When it comes to ADHD, some researchers suggest that medical textbooks provide inaccurate and misleading information.
Relieving Poverty Significantly Improves Mental Health
Giving money to people diagnosed with severe mental health issues can significantly improve depression and anxiety. A new study, published in the October issue of the Journal of Community Mental Health, found that giving about $73 US dollars per month for recreational spending can also reduce social isolation and strengthen a sense of self.
After the Black-Box: Majority of Children Starting SSRIs Still Receiving Too High of Dose
In 2004, the FDA added a black-box warning to SSRI antidepressants on the increased risk of suicide among children taking these drugs. A new study suggests that this warning has increased the proportion of children who begin an antidepressant on a low dose, but the majority are still receiving higher than recommended doses.
Better Outcomes Off Medication for Those Recovered from First-Episode Schizophrenia
A new study has found that of 10 people who were fully recovered from their first episode of schizophrenia (FES), those not taking antipsychotics did better in terms of cognitive, social, and role functioning—and reached full recovery more quickly.
Study Finds Heavy Metal Music Beneficial to Mental Health
A new study highlights the role heavy metal music plays in the mental health of adolescents facing adversity.
Researchers Challenge Industry-Friendly Depression Guideline
Review of a new mixed depression guideline reveals financial bias of guideline developers and lack of evidence supporting recommendations for prescribing of antipsychotics.
Researchers Find Bias in Industry-Funded Continuing Medical Education
Industry-funded continuing medical education (CME) influences physicians to prescribe more opioids, focus less on the consequences.
Fighting for the Meaning of Madness: An Interview with Dr. John Read
Akansha Vaswani interviews Dr. John Read about the influences on his work and his research on madness, psychosis, and the mental health industry.
Individuals with Psychosis Symptoms More Likely to be Victimized
Individuals diagnosed with a psychotic disorder are 4-6 times more likely than the general population to experience victimization.
How the News Frames the Opioid Epidemic
US news coverage has primarily framed the opioid drug abuse epidemic as a criminal justice issue rather than a public health problem, according to new research published ahead of print in the Journal of Psychiatric Services. The media’s framing of the epidemic may increase stigma against those who develop a dependency on prescription drugs and distract political attention from public-health oriented solutions, such as increased access to substance abuse recovery treatments.
Targeting Hypocrisy Reduces Islamophobia and Collective Blame of Muslims
Interventions calling attention to participants’ hypocrisy proved effective in reducing Islamophobia and collective blame of Muslims for individual acts of violence.
Confusion Over Antipsychotic Dosing Data in RAISE Study
Yesterday, the New York Times reported that schizophrenia patients in an experimental treatment program (RAISE) who experienced better outcomes had been on lower doses of antipsychotics than normal. However, the article published in the American Journal of Psychiatry on Tuesday did not divulge any data on the varying antipsychotic drug doses in the different study groups.
New Study Concludes that Antidepressants are “Largely Ineffective and Potentially Harmful”
A new study published in Frontiers in Psychiatry concludes that “antidepressants are largely ineffective and potentially harmful.”
Digital Media Use Linked to Increase in ADHD Symptoms
Increased frequency of digital media use can increase symptoms of ADHD among adolescents, study finds.
Outcome Reporting Bias in Antipsychotic Medication Trials
A new study in the journal Translational Psychiatry, an influential journal in biological psychiatry published by Nature, challenges the state of the research on antipsychotic drugs.
Researchers Set the Record Straight on Controversial Zoloft Study
An issue of Lancet Psychiatry is devoted to clarifying the lack of efficacy for Zoloft (sertraline).
Speaking, Not Texting, May Prevent Dehumanization in Disagreements
Researchers found participants were less likely to dehumanize those with whom they disagreed when they heard their voices.
Experts Call on Presidential Candidates to Improve Study Transparency
In an open letter to all US presidential candidates published Thursday in the BMJ, a group of global health care experts assert that current research regulations allow drug companies to publish incomplete and misleading results. They ask the candidates to declare whether they support improved transparency measures that would make data on drug studies publically available and open to scrutiny.
Researchers Expose Pharmaceutical Industry Misconduct and Corruption
Corruption of pharmaceutical industry sponsored clinical trials identified as a “major obstacle” facing evidence-based medicine.
Anti-Stigma Campaigns Enable Inequality, Sociologists Argue
Scholars contend that stigma functions as a mechanism of power in analysis of UK Heads Together mental health campaign.
